| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $41,879,090 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM130399 | Analysis of the Metabolic Capabilities of Prokaryotic Cells | 000 | 8 | NIH | 4/2/2026 | $708,492 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31HD119991 | Mutual communications between RhoA signaling and P4 signaling in luteal cells and the uterus during early pregnancy | 000 | 2 | NIH | 6/30/2026 | $44,279 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES033892 | Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | 000 | 5 | NIH | 2/6/2026 | $600,217 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01DK135847 | Neurodevelopment of executive function, appetite regulation, and obesity in children and adolescents | 002 | 4 | NIH | 6/12/2026 | $155,293 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI185090 | Optimization of UltraPCR for detection of and assessment of treatment outcomes in Trypanosoma cruzi infection | 000 | 2 | NIH | 2/6/2026 | $574,051 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182993 | Assessing the Mycobacterium tuberculosis carriage state | 001 | 2 | NIH | 6/23/2026 | $104,370 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182993 | Assessing the Mycobacterium tuberculosis carriage state | 000 | 2 | NIH | 5/1/2026 | $42,825 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS135412 | Characterizing and treating peripheral nervous system dysfunction in Sanfilippo Syndrome | 000 | 2 | NIH | 2/5/2026 | $188,750 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 001 | 3 | NIH | 3/24/2026 | $14,374 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 000 | 3 | NIH | 2/13/2026 | $455,140 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI180075 | Treatment outcome requirements for disease prevention in Chagas disease | 000 | 3 | NIH | 6/25/2026 | $628,518 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 001 | 4 | NIH | 2/26/2026 | $25,149 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 000 | 4 | NIH | 2/20/2026 | $409,159 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 001 | 12 | NIH | 3/19/2026 | $37,769 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 000 | 12 | NIH | 1/21/2026 | $339,923 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153268 | Epigenomic consequences of breakage-fusion-bridge cycling | 000 | 3 | NIH | 6/1/2026 | $368,444 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 000 | 3 | NIH | 5/13/2026 | $547,363 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 4 | NIH | 12/8/2025 | $477,462 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 4 | NIH | 12/31/2025 | $640,850 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 000 | 4 | NIH | 5/27/2026 | $408,435 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 4 | NIH | 2/5/2026 | $624,074 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 4 | NIH | 2/11/2026 | $54,644 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 000 | 8 | NIH | 5/5/2026 | $340,622 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 3 | NIH | 1/6/2026 | $660,492 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD114750 | Mechanisms of uterine fluid absorption during early pregnancy | 000 | 3 | NIH | 3/24/2026 | $637,476 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AT012783 | Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health | 000 | 3 | NIH | 4/29/2026 | $523,612 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 001 | 3 | NIH | 3/23/2026 | $54,481 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 000 | 3 | NIH | 1/13/2026 | $490,327 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158187 | Molecular mechanism of MFS and MOP lipid transporters in cell wall biosynthesis. | 000 | 2 | NIH | 4/17/2026 | $362,062 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM163754 | Enhancing Faculty Mentorship of PhD Students in Biomedical Research | 000 | 1 | NIH | 6/11/2026 | $342,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153189 | Analysis of Metabolic Stress and Functional Integration in Prokaryotes | 000 | 3 | NIH | 4/2/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152134 | Control and function of repressive chromatin domains | 000 | 3 | NIH | 5/8/2026 | $365,002 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM151237 | Developmental mechanisms that buffer mutational load in plants | 000 | 4 | NIH | 5/19/2026 | $359,629 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 001 | 1 | NIH | 1/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 000 | 1 | NIH | 1/16/2026 | $43,700 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 002 | 1 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS133739 | Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery | 000 | 3 | NIH | 6/19/2026 | $622,410 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK132673 | Transfer application - Leptin in the VMH and energy balance | 001 | 5 | NIH | 6/19/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 4 | NIH | 2/11/2026 | $73,682 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 4 | NIH | 2/5/2026 | $111,577 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 4 | NIH | 2/5/2026 | $50,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL170574 | Prevention of catheter related infections via photoactive nitric oxide delivery device | 001 | 4 | NIH | 4/29/2026 | $458,948 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM147209 | Spatial genetics investigation of multinucleated cells | 000 | 5 | NIH | 6/19/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147312 | Supplement: Functional Analysis of the Anti-Müllerian Hormone as a Convergently Acquired Master Sex Determination Gene | 001 | 4 | NIH | 7/6/2026 | $174,832 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147312 | Supplement: Functional Analysis of the Anti-Müllerian Hormone as a Convergently Acquired Master Sex Determination Gene | 000 | 4 | NIH | 4/3/2026 | $310,896 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T1C54770 | Maternal and Child Health Public Health Catalyst Program | 00 | 2 | HRSA | 5/18/2026 | $135,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K22AG088111 | Molecular Determinants of Age-Related Cognitive Decline in the Basal Forebrain to Lateral Entorhinal Cortex Circuit | 000 | 1 | NIH | 3/19/2026 | $198,352 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DE035487 | Engineered Synthetic Low-Density Lipoprotein Nanoparticles for Enhanced Cancer Immunotherapy in Head and Neck Cancer | 000 | 1 | NIH | 2/18/2026 | $644,452 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI196741 | Novel approaches to predict strength and breadth of influenza vaccine response | 000 | 1 | NIH | 5/12/2026 | $805,866 |
|
